Purdue Pharma announced its settlement with all 55 attorneys general on Monday after longstanding allegations.

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

A judge intends to rule this week on a plan for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids.

Members of the Sackler family, the billionaire owners of Purdue Pharma, reached an agreement to pay up to $6 billion to resolve lawsuits alleging the OxyContin maker helped fuel the opioid epidemic.

Raymond and Beverly Sackler (credit: Taco van der Eb/Hollandse Hoogte/Redux). Taco van der Eb/Hollandse Hoogte/Redux. Just a few years ago, the Sackler family was best known for their ...

For decades the Sackler family, which owned Purdue, knowingly marketed highly addictive painkillers, including Oxycontin. Friends and family members of people who have died during the opioid ...

The Sackler family, which owns Purdue Pharma, used Swiss and other hidden bank accounts to transfer around $1 billion from the company to themselves, the New York attorney general’s office ...

Members of the Sackler family withdrew more than $10 billion from Purdue Pharma and put the money in family trusts and holding companies as pressure intensified over the nation’s opioid epidemic ...

The family who owns Purdue Pharma, manufacturer of the narcotic painkiller OxyContin, transferred $1.36 billion to overseas accounts and affiliated companies after 2008, part of $10.3 billion in ...

Members of the Sackler family boosted their contribution to the settlement of opioids lawsuits to $4.2 billion under a restructuring plan filed overnight by Purdue Pharma with a federal bankruptcy ...